GL Earnings Date: Feb 3, 2027 (Estimated) — Globe Life Inc.
NYSE · Financials · Insurance - Life
Updated
When is GL's next earnings date?
Globe Life Inc. (GL) is expected to report Q4 2026 earnings on Wednesday, February 3, 2027 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $3.78 on revenue of $1.64B.
How did GL do in its last earnings report?
In its most recent report on Oct 21, 2026 (Q3 2026), Globe Life Inc. posted EPS of $4.84 versus the $4.90 estimate, a miss of 1.2%. Revenue was $1.60B against a $1.61B estimate. The stock's 1-day post-earnings move was -0.7%.
How much does GL stock move after earnings?
GL beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 2.2% (up or down) in the day after earnings.
About Globe Life Inc.
Globe Life Inc. delivers diverse life insurance and supplementary health coverage, alongside annuity products, targeting households in the lower-middle to middle-income brackets throughout the United States. The company's operations are structured into four key segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its offerings encompass whole life, term life, and other life protection plans; supplemental health benefits like Medicare supplements, critical illness, and accident policies; and both single-premium and flexible-premium deferred annuities. Founded in 1979 and headquartered in McKinney, Texas, the enterprise rebranded from Torchmark Corporation to Globe Life Inc. in August 2019.
🤖 AI Earnings Analysis
Globe Life’s Q3 was mixed: EPS of $4.84 missed estimates by $0.06 and revenue of $1.6B was roughly in line, despite premium growth and higher investment income. Its $15.55–$15.95 EPS outlook supports continued earnings growth, but the modest year-over-year EPS increase tempers the bullish case.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-21 | Q3 2026 | 4.90 | 4.84 | -1.22% | $1.60B | ❌ Miss | -0.71% | -6.63% | — |
| 2026-07-22 | Q2 2026 | 3.68 | 3.61 | -1.90% | $1.60B | ❌ Miss | -7.02% | -2.35% | -7.34% |
| 2026-04-22 | Q1 2026 | 3.48 | 3.43 | -1.44% | $1.56B | ❌ Miss | +1.80% | +0.85% | +3.54% |
| 2026-02-04 | Q4 2025 | 3.44 | 3.39 | -1.45% | $1.52B | ❌ Miss | +1.47% | -0.62% | -1.82% |
| 2025-10-22 | Q3 2025 | 4.54 | 4.81 | +5.95% | $1.51B | ✅ Beat | +0.04% | -2.88% | -3.88% |
| 2025-04-30 | Q1 2025 | 3.24 | 3.07 | -5.25% | $1.48B | ❌ Miss | -4.55% | -1.93% | -1.20% |
| 2024-10-23 | Q3 2024 | 3.06 | 3.49 | +14.05% | $1.46B | ✅ Beat | -1.33% | -3.49% | -1.69% |
| 2024-07-24 | Q2 2024 | 2.90 | 2.97 | +2.41% | $1.44B | ✅ Beat | +0.91% | +5.06% | +12.10% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $1.30B total
| Segment | Share | Revenue | YoY | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|
| Life | 66.3% | $860.8M | +2.5% | $818.6M | $1.64B | $829.9M | $839.5M |
| Health | 33.7% | $436.9M | +15.5% | $354.0M | $710.0M | $369.8M | $378.1M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.